Yuhan and Cyrus Partner to Develop Innovative Small-Molecule Anti-Cancer Drug
Expect synergy between Cyrus’ anti-cancer drug discovery capabilities and Yuhan’s translational clinical research capabilities Looking forward to quickly discovering the second Lexraza with global competitiveness From left, Kim Byung-moon, CEO of Cyrus Therapeutics, and Cho Wook-je, CEO of Yuhan Corporation (Photo Credit=Yuhan Corporation) [바이오타임즈] Yuhan Corp. (CEO Wook-Je Cho) announced that it had signed a … Read more